Z-1568-2013 Class III Terminated

Recalled by Integra LifeSciences Corp. — Plainsboro, NJ

FDA device recall Z-1568-2013 was initiated by Integra LifeSciences Corp. on Jun 3, 2013 and is designated Class III. Reason for recall: As a result of a quality review, labelling content discrepancies were identified between the Instruction for Use (IFU) distributed in the US with the Ascension CMC and the content that is cleared by… The recall status is terminated (terminated Oct 8, 2014). Affected quantity: 467 devices.

Recall details

Product Type
Devices
Report Date
Jul 3, 2013
Initiation Date
Jun 3, 2013
Termination Date
Oct 8, 2014
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
467 devices

Product description

CMC Saddle Product Usage: The Ascension CMC is intended to resurface the proximal end of the first metacarpal in cases of rheumatoid arthritis, traumatic arthritis, osteo-arthritis, or post-fracture deformation or bone loss which present as either a painful, unstable thumb, or a thumb with limited range of motion. This is an uncemented prosthesis designed for press fit use only.

Reason for recall

As a result of a quality review, labelling content discrepancies were identified between the Instruction for Use (IFU) distributed in the US with the Ascension CMC and the content that is cleared by FDA.

Distribution pattern

USA Nationwide Distribution

Code information

Lot/Serial Number: 111602, 110864, 102815, 091515, 092563, 110863. Product/Catalogue No: CMC-410-10, CMC-410-20, CMC-410-30, CMC-410-40.

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1568-2013
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1568-2013. Report a data issue: hello@regdatalab.com.